An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA gyrase Suppressive Features for The Treatment of Coronaviral & adenoviral Infections
Open data API in a single place
Provided by Le Gouvernement du Grand-Duché de Luxembourg
Get early access to An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA gyrase Suppressive Features for The Treatment of Coronaviral & adenoviral Infections API!
Let us know and we will figure it out for you.
Dataset information
Country of origin
Updated
Created
2020.04.21
Available languages
French
Keywords
sante, adenoviral, covid-19, antiviral, health
Datasource
Quality scoring
170
Dataset description
An Antiviral Formulation Consisting of 3 protopanaxatriol-Class glucopyranoside Analouges, A Semi-Synthetic flavonol Glycoside Derivative and an Immuno-modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA Polymerase and Viral DNA gyrase and Modulating Anti-Inflammatory Cytokines Tnf-Alpha, IL-6, Nf-Kappa B and PGE2 to Suppress Potential Cytokine Storms simultaneously.
Inventors: ERDAL CAN ALKOCLAR & METEHAN YESIL
Build on reliable and scalable technology
FAQ
Frequently Asked Questions
Some basic informations about API Store ®.
Operation and development of APIs are currently fully funded by company Apitalks and its usage is for free.
Yes, you can.
All important information such as time of last update, license and other information are in response of each API call.
In case of major update that would not be compatible with previous version of API, we keep for 30 days both versions so you will have enough time to transfer to new version. We will inform you about the changes in advance by e-mail.
Didn't find the API you need?
Let us know and we will figure it out for you.
API Store provides access to European Open Data via scalable and reliable REST API interface.
Copyright © 2024. Made with ♥ by Apitalks